Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Hepatology. 2014 Mar 1;59(4):1311–1319. doi: 10.1002/hep.26920

Fig. 2.

Fig. 2

Cumulative Risk of Advanced Disease by Donor Type. The unadjusted cumulative risk of advanced disease by donor type based on (A) histological data and (B) histological and clinical data was not significantly different in LDLT (dashed line) and DDLT (solid line) groups (P > 0.05 for both comparisons by log-rank test).